Editorial comment regarding H5N1 influenza article in this issue

Journal of Infectious Diseases

Volumn 207, Issue 2, 2013, Pages 207-

  Hirsch, Martin S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CYTOKINE; RNA POLYMERASE;

CYTOKINE STORM; HEALTH CENTER; HUMAN; INFLUENZA A (H5N1); INFLUENZA VIRUS A H5N1; MACROPHAGE; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; NOTE; PATHOGENICITY; PRIORITY JOURNAL; PUBLIC HEALTH; UNITED STATES; VIRUS VIRULENCE;

EID: 84871723032     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis528     Document Type: Note

References (3)

1. Sakabe S, Takano R, Nagamura-Inoue T, et al. Differences in cytokine production in human macrophages and in virulence in mice are attributable to the PA protein of highly pathogenic H5N1 influenza viruses. J Infect Dis 2013; 207:262-71.
2. The United States Government Policy for Oversight ofLife Sciences Dual Use Research of Concern. 2012: http://oba.od.nih.gov/oba/bio security/pdf/united-states-government-policy-for-oversight-of-durc-final- version-032812.pdf. Accessed 2 May 2012.
3. Donis RO, Cox NJ. So many questions, so little time. J Infect Dis 2013; 207:208-10.